^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BGB-B167

    i
    Other names: BGB-B167
    Associations
    News
    Trials
    Company:
    BeiGene
    Drug class:
    CD137 agonist, CEACAM5 inhibitor
    Related drugs:
    Associations
    News
    Trials